Overview
Current Appointments & Affiliations
Professor of Pediatrics
·
2021 - Present
Pediatrics, Cardiology,
Pediatrics
Chief, Division of Pediatric Cardiology
·
2022 - Present
Pediatrics, Cardiology,
Pediatrics
Member in the Duke Clinical Research Institute
·
2012 - Present
Duke Clinical Research Institute,
Institutes and Centers
Associate of the Duke Initiative for Science & Society
·
2017 - Present
Duke Science & Society,
University Initiatives & Academic Support Units
In the News
View All News
Recent Publications
National practice patterns for the use of regional anesthesia for pediatric cardiac surgery: An analysis of the Society of Thoracic Surgeons congenital heart surgery database.
Journal Article J Clin Anesth · March 2025 BACKGROUND: Complications associated with suboptimal pain management after pediatric cardiac surgery have increased interest in regional anesthesia (RA). We sought to evaluate national trends and explore the association of RA with postoperative outcomes fo ... Full text Link to item CiteA Bayesian Re-analysis of the Steroids to Reduce Systemic Inflammation after Infant Heart Surgery (STRESS) Trial.
Journal Article medRxiv · February 12, 2025 BACKGROUND: Prophylactic steroids are often used to reduce the systemic inflammatory response to cardiopulmonary bypass in infants undergoing heart surgery. The STRESS trial found that the likelihood of a worse outcome did not differ between infants random ... Full text Link to item CiteUrine biomarkers, acute kidney injury, and fluid overload in neonatal cardiac surgery.
Conference Cardiol Young · February 6, 2025 BACKGROUND: Cardiac surgery-associated acute kidney injury (CS-AKI) and fluid overload (FO) are common among neonates who undergo cardiopulmonary bypass, and increase mortality risk. Current diagnostic criteria may delay diagnosis. Thus, there is a need to ... Full text Link to item CiteRecent Grants
CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease
ResearchPrincipal Investigator · Awarded by Research Institute at Nationwide Children's Hospital · 2024 - 2030A PHASE 2/3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AFICAMTEN IN A PEDIATRIC POPULATION WITH SYMPTOMATIC OBSTRUC
Clinical TrialPrincipal Investigator · Awarded by Cytokinetics, Inc. · 2025 - 2028Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028View All Grants
Education, Training & Certifications
Wake Forest University ·
2002
M.D.